糖尿病、肾病和心血管疾病患者 "病假 "期间的药物管理:以理论为指导的干预设计与实施方法》。

IF 2.3 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM Canadian Journal of Diabetes Pub Date : 2024-06-01 DOI:10.1016/j.jcjd.2024.02.003
Kaitlyn E. Watson BPharm (Hons), PhD, GradCertAppPharmPrac, FHEA , Kirnvir Dhaliwal RN, MN, PhD , Eleanor Benterud RN, MN , Sandra Robertshaw , Nancy Verdin , Ella McMurtry , Nicole Lamont MBT, BHSc , Kelsea M. Drall MSc , Sarah Gill , David J.T. Campbell MD, MSc, PhD, FRCPC , Kerry McBrien MD, MPH, CCFP , Ross T. Tsuyuki BSc(Pharm), PharmD, MSc, FCSHP, FACC, FCAHS, ISHF , Neesh Pannu MD, SM , Matthew T. James MD, PhD, FRCPC , Maoliosa Donald PhD, BScPT
{"title":"糖尿病、肾病和心血管疾病患者 \"病假 \"期间的药物管理:以理论为指导的干预设计与实施方法》。","authors":"Kaitlyn E. Watson BPharm (Hons), PhD, GradCertAppPharmPrac, FHEA ,&nbsp;Kirnvir Dhaliwal RN, MN, PhD ,&nbsp;Eleanor Benterud RN, MN ,&nbsp;Sandra Robertshaw ,&nbsp;Nancy Verdin ,&nbsp;Ella McMurtry ,&nbsp;Nicole Lamont MBT, BHSc ,&nbsp;Kelsea M. Drall MSc ,&nbsp;Sarah Gill ,&nbsp;David J.T. Campbell MD, MSc, PhD, FRCPC ,&nbsp;Kerry McBrien MD, MPH, CCFP ,&nbsp;Ross T. Tsuyuki BSc(Pharm), PharmD, MSc, FCSHP, FACC, FCAHS, ISHF ,&nbsp;Neesh Pannu MD, SM ,&nbsp;Matthew T. James MD, PhD, FRCPC ,&nbsp;Maoliosa Donald PhD, BScPT","doi":"10.1016/j.jcjd.2024.02.003","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><p>Our aim in this work was to 1) explore barriers and enablers to patient and health-care provider (HCP) behaviours related to sick-day medication guidance (SDMG), 2) identify theory-informed strategies to advise SDMG intervention design, and 3) obtain perspectives on an eHealth tool for this purpose.</p></div><div><h3>Methods</h3><p>A qualitative descriptive study using qualitative conventional content analysis was undertaken. Interviews and focus groups were held with patients and HCPs from January 2021 to April 2022. Data were analyzed using the Behaviour Change Wheel and Theoretical Domains Framework to inform intervention design.</p></div><div><h3>Results</h3><p>Forty-eight people (20 patients, 13 pharmacists, 12 family physicians, and 3 nurse practitioners) participated in this study. Three interventions were designed to address the identified barriers and enablers: 1) prescriptions provided by a community-based care provider, 2) pharmacists adding a label to at-risk medications, and 3) built-in prompts for prescribing and dispensing software. Most participants accepted the concept of an eHealth tool and identified pharmacists as the ideal point-of-care provider. Challenges for an eHealth tool were raised, including credibility, privacy of data, medical liability, clinician remuneration and workload impact, and equitable access to use of the tool.</p></div><div><h3>Conclusions</h3><p>Patients and HCPs endorsed non-technology and eHealth innovations as strategies to aid in the delivery of SDMG. These findings can guide the design of future theory-informed SDMG interventions.</p></div>","PeriodicalId":9565,"journal":{"name":"Canadian Journal of Diabetes","volume":null,"pages":null},"PeriodicalIF":2.3000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1499267124000455/pdfft?md5=4af92579e548299ac5f7b13571a62efd&pid=1-s2.0-S1499267124000455-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Managing Medications During “Sick Days” in Patients With Diabetes, Kidney, and Cardiovascular Conditions: A Theory-informed Approach to Intervention Design and Implementation\",\"authors\":\"Kaitlyn E. Watson BPharm (Hons), PhD, GradCertAppPharmPrac, FHEA ,&nbsp;Kirnvir Dhaliwal RN, MN, PhD ,&nbsp;Eleanor Benterud RN, MN ,&nbsp;Sandra Robertshaw ,&nbsp;Nancy Verdin ,&nbsp;Ella McMurtry ,&nbsp;Nicole Lamont MBT, BHSc ,&nbsp;Kelsea M. Drall MSc ,&nbsp;Sarah Gill ,&nbsp;David J.T. Campbell MD, MSc, PhD, FRCPC ,&nbsp;Kerry McBrien MD, MPH, CCFP ,&nbsp;Ross T. Tsuyuki BSc(Pharm), PharmD, MSc, FCSHP, FACC, FCAHS, ISHF ,&nbsp;Neesh Pannu MD, SM ,&nbsp;Matthew T. James MD, PhD, FRCPC ,&nbsp;Maoliosa Donald PhD, BScPT\",\"doi\":\"10.1016/j.jcjd.2024.02.003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objectives</h3><p>Our aim in this work was to 1) explore barriers and enablers to patient and health-care provider (HCP) behaviours related to sick-day medication guidance (SDMG), 2) identify theory-informed strategies to advise SDMG intervention design, and 3) obtain perspectives on an eHealth tool for this purpose.</p></div><div><h3>Methods</h3><p>A qualitative descriptive study using qualitative conventional content analysis was undertaken. Interviews and focus groups were held with patients and HCPs from January 2021 to April 2022. Data were analyzed using the Behaviour Change Wheel and Theoretical Domains Framework to inform intervention design.</p></div><div><h3>Results</h3><p>Forty-eight people (20 patients, 13 pharmacists, 12 family physicians, and 3 nurse practitioners) participated in this study. Three interventions were designed to address the identified barriers and enablers: 1) prescriptions provided by a community-based care provider, 2) pharmacists adding a label to at-risk medications, and 3) built-in prompts for prescribing and dispensing software. Most participants accepted the concept of an eHealth tool and identified pharmacists as the ideal point-of-care provider. Challenges for an eHealth tool were raised, including credibility, privacy of data, medical liability, clinician remuneration and workload impact, and equitable access to use of the tool.</p></div><div><h3>Conclusions</h3><p>Patients and HCPs endorsed non-technology and eHealth innovations as strategies to aid in the delivery of SDMG. These findings can guide the design of future theory-informed SDMG interventions.</p></div>\",\"PeriodicalId\":9565,\"journal\":{\"name\":\"Canadian Journal of Diabetes\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2024-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S1499267124000455/pdfft?md5=4af92579e548299ac5f7b13571a62efd&pid=1-s2.0-S1499267124000455-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Canadian Journal of Diabetes\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1499267124000455\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian Journal of Diabetes","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1499267124000455","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

摘要

目的目的:(1)探索患者和医疗保健提供者(HCPs)与 SDMG 相关行为的障碍和促进因素;(2)确定理论指导下的策略,为 SDMG 干预设计提供建议;以及(3)了解对用于此目的的电子健康工具的看法:采用常规定性内容分析法进行定性描述研究。从 2021 年 1 月至 2022 年 4 月,与患者和保健医生进行了访谈和焦点小组讨论。采用行为改变轮和理论领域框架对数据进行分析,为干预设计提供依据:48人(20名患者、13名药剂师、12名家庭医生和3名执业护士)参加了此次活动。针对已确定的障碍和促进因素设计了三种干预措施:(1)由社区医疗服务提供者提供处方;(2)药剂师在高风险药物上添加标签;(3)处方和配药软件内置提示。大多数与会者接受了电子健康工具的概念,并认为药剂师是理想的护理点提供者。电子健康工具面临的挑战包括可信度、数据隐私、医疗责任、临床医师薪酬和工作量影响以及公平使用:结论:患者和医疗保健提供者赞同将非技术和电子健康创新作为帮助提供 SDMG 的策略。这些研究结果可为今后设计基于理论的 SDMG 干预措施提供指导。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Managing Medications During “Sick Days” in Patients With Diabetes, Kidney, and Cardiovascular Conditions: A Theory-informed Approach to Intervention Design and Implementation

Objectives

Our aim in this work was to 1) explore barriers and enablers to patient and health-care provider (HCP) behaviours related to sick-day medication guidance (SDMG), 2) identify theory-informed strategies to advise SDMG intervention design, and 3) obtain perspectives on an eHealth tool for this purpose.

Methods

A qualitative descriptive study using qualitative conventional content analysis was undertaken. Interviews and focus groups were held with patients and HCPs from January 2021 to April 2022. Data were analyzed using the Behaviour Change Wheel and Theoretical Domains Framework to inform intervention design.

Results

Forty-eight people (20 patients, 13 pharmacists, 12 family physicians, and 3 nurse practitioners) participated in this study. Three interventions were designed to address the identified barriers and enablers: 1) prescriptions provided by a community-based care provider, 2) pharmacists adding a label to at-risk medications, and 3) built-in prompts for prescribing and dispensing software. Most participants accepted the concept of an eHealth tool and identified pharmacists as the ideal point-of-care provider. Challenges for an eHealth tool were raised, including credibility, privacy of data, medical liability, clinician remuneration and workload impact, and equitable access to use of the tool.

Conclusions

Patients and HCPs endorsed non-technology and eHealth innovations as strategies to aid in the delivery of SDMG. These findings can guide the design of future theory-informed SDMG interventions.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Canadian Journal of Diabetes
Canadian Journal of Diabetes ENDOCRINOLOGY & METABOLISM-
CiteScore
4.80
自引率
4.00%
发文量
130
审稿时长
54 days
期刊介绍: The Canadian Journal of Diabetes is Canada''s only diabetes-oriented, peer-reviewed, interdisciplinary journal for diabetes health-care professionals. Published bimonthly, the Canadian Journal of Diabetes contains original articles; reviews; case reports; shorter articles such as Perspectives in Practice, Practical Diabetes and Innovations in Diabetes Care; Diabetes Dilemmas and Letters to the Editor.
期刊最新文献
Masthead Table of Contents Editorial Board Calling All Clinicians: A Brief 5-Step Model for Exploring Diabetes Distress in Routine Diabetes Care Association of Sodium-Glucose Cotransporter-2 Inhibitors vs Dipeptidyl Peptidase-4 Inhibitors With Pneumonia, COVID-19, and Other Adverse Respiratory Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1